High bone density due to a mutation in LDL-receptor-related protein 5 [1] (multiple letters)

New England Journal of Medicine

Volumn 347, Issue 12, 2002, Pages 943-944

  Little, Randall D ^a   Recker, Robert R ^a   Johnson, Mark L ^a   Hofbauer, Lorenz C ^a   Maisch, Bernhard ^a   Schaefer, Juergen R ^a   Boyden, Lynn ^a   Insogna, Karl ^a   Lifton, Richard P ^a  

^a GENOME THERAPEUTICS CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRONECTIN; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN 5; OSTEOCALCIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; LIPOPROTEIN RECEPTOR RELATED PROTEIN 5; LOW DENSITY LIPOPROTEIN RECEPTOR; CARRIER PROTEIN; CELL RECEPTOR; GLYCOPROTEIN; LIPOPROTEIN; MEMBRANE PROTEIN; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; TNFRSF11A PROTEIN, HUMAN; TNFRSF11B PROTEIN, HUMAN; TNFSF11 PROTEIN, HUMAN; TUMOR NECROSIS FACTOR RECEPTOR;

AMINO ACID SEQUENCE; BONE DENSITY; BONE MASS; BONE REMODELING; CLINICAL FEATURE; GENETIC ANALYSIS; HUMAN; LETTER; MORPHOLOGY; OSSIFICATION; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK FACTOR; SCORING SYSTEM; SEQUENCE ANALYSIS; BONE DEVELOPMENT; GENETICS; NOTE; PHYSIOLOGY; POINT MUTATION; SIGNAL TRANSDUCTION; BLOOD; METABOLISM; MUTATION;

BONE DENSITY; HUMANS; LDL-RECEPTOR RELATED PROTEINS; OSTEOGENESIS; PHENOTYPE; POINT MUTATION; RECEPTORS, LDL; SIGNAL TRANSDUCTION; CARRIER PROTEINS; GLYCOPROTEINS; LIPOPROTEINS; MEMBRANE GLYCOPROTEINS; MUTATION; OSTEOPROTEGERIN; RANK LIGAND; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, TUMOR NECROSIS FACTOR;

EID: 0037136577     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200209193471216     Document Type: Letter

References (0)